REQUEST A DEMO
Total
USD $0.00
Search more companies

Medicina Critica y Cuidado Intensivo Jireh Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Medicina Critica y Cuidado Intensivo Jireh Sas Profile Updated: January 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Medicina Critica y Cuidado Intensivo Jireh Sas is a company based in Colombia, with its head office in Bogota D.C.. The company operates in the Ambulatory Health Care Services sector. It was first established on October 07, 2020. The company’s latest financial report indicates a net sales revenue increase of 10.93% in 2022. Over the same period, its total assets grew by 48.32%. In, 2022, the company’s net profit margin decreased by 4.77%.

Headquarters
Cl 97 N 70 89 To 1 Ap 1201 Conj Portal de Pontevedra Iii
Bogota D.C.; Bogota D.C; Postal Code: 0906

Contact Details: Purchase the Medicina Critica y Cuidado Intensivo Jireh Sas report to view the information.

Basic Information
Outstanding Shares:
Purchase the Medicina Critica y Cuidado Intensivo Jireh Sas report to view the information.
Incorporation Date:
October 07, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Medicina Critica y Cuidado Intensivo Jireh Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
10.93%
Total operating revenue
10.93%
Operating profit (EBIT)
-12.59%
Net Profit (Loss) for the Period
-45.93%
Total assets
48.32%
Total equity
86.66%
Operating Profit Margin (ROS)
-3.03%
Net Profit Margin
-4.77%
Return on Equity (ROE)
-62.75%
Quick Ratio
0.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?